Folate receptor targeted nanoparticles containing niraparib and doxorubicin for treatment of high grade serous ovarian cancer
L. Wang, J. C. Evans, L. Ahmed, C. Allen
This paper demonstrates the synergistic potential of niraparib and doxorubicin in ovarian cancer treatment and develops folate receptor-targeted nanoparticles for their delivery.
bioRxiv · Aug 29, 2022 · PreprintCancer Biology